Concepedia

Dingwei Ye

DY

Statistics

Publications

47

Citations

2.5K

H-Index

22

Active since

1993

Affiliations

Fudan University Shanghai Cancer Center(Current)

Shanghai Medical College of Fudan University

Fudan University

Sun Yat-sen University

Sichuan University

Dingwei Ye is an author at Fudan University Shanghai Cancer Center specializing in oncology, medicine, and renal cell carcinoma.

Publications per year

1993–2025

47

Publications

47

Nivolumab plus Gemcitabine–Cisplatin in Advanced Urothelial Carcinoma

Michiel S. van der Heijden, Guru Sonpavde, Thomas Powles et al. · New England Journal of Medicine · 2023 · 462 citations · Full text

Medicine, Oncology, Pharmacotherapy +17

Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas

Pu Wang, Qiongzhu Dong, C. Zhang et al. · Oncogene · 2012 · 389 citations

Medicine, Genetics, Oncology +14

Axitinib versus placebo as an adjuvant treatment of renal cell carcinoma: results from the phase III, randomized ATLAS trial

Marine Gross‐Goupil, Tae‐Geon Kwon, Masatoshi Eto et al. · Annals of Oncology · 2018 · 257 citations · Full text

Medicine, Oncology, Pharmacology +17

Constitutively Active AR-V7 Plays an Essential Role in the Development and Progression of Castration-Resistant Prostate Cancer

Yuanyuan Qu, Bo Dai, Dingwei Ye et al. · Scientific Reports · 2015 · 164 citations · Full text

Medicine, Cancer Biology, Oncology +17

Tislelizumab in Asian patients with previously treated locally advanced or metastatic urothelial carcinoma

Dingwei Ye, Jiyan Liu, Aiping Zhou et al. · Cancer Science · 2020 · 116 citations · Full text

Life Sciences, Immunology, Oncology +17

1–5 of 47